These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 7939318

  • 1. [How to enhance the efficacy of radiotherapy].
    Calais G.
    Rev Prat; 1994 Apr 15; 44(8):1021-5. PubMed ID: 7939318
    [Abstract] [Full Text] [Related]

  • 2. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD, Flickinger JC, Larson D.
    Oncologist; 1997 Apr 15; 2(1):59-61. PubMed ID: 10388030
    [Abstract] [Full Text] [Related]

  • 3. High dose daily amifostine and hypofractionated intensively accelerated radiotherapy for locally advanced breast cancer. A phase I/II study and report on early and late sequellae.
    Koukourakis MI, Yannakakis D.
    Anticancer Res; 2001 Apr 15; 21(4B):2973-8. PubMed ID: 11712796
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Wang LJ, Qian H, Fu XL, Yang H, Wu KL, Zhao S.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):70-5. PubMed ID: 15629596
    [Abstract] [Full Text] [Related]

  • 5. MR guided cancer treatment system for an elevated therapeutic index - a macroscopic approach.
    Myhr G.
    Med Hypotheses; 2008 Jan 01; 70(3):665-70. PubMed ID: 17765401
    [Abstract] [Full Text] [Related]

  • 6. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.
    Jpn J Clin Oncol; 1994 Oct 01; 24(5):275-81. PubMed ID: 7967106
    [Abstract] [Full Text] [Related]

  • 7. Multiple drug chemotherapy combined with multiple fractions per day (MFD) radiotherapy in an experimental solid tumor model.
    Hopkins HA, Looney WB, Carter WH, Reto DC, Campbell ED.
    In Vivo; 1994 Oct 01; 8(1):107-12. PubMed ID: 8054501
    [Abstract] [Full Text] [Related]

  • 8. Impact of tumor repopulation on radiotherapy planning.
    Wang JZ, Li XA.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):220-7. PubMed ID: 15629615
    [Abstract] [Full Text] [Related]

  • 9. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA, Holden SA, Ara G, Dupuis NP, Goff D.
    Cancer J Sci Am; 1995 Jan 01; 1(1):43-8. PubMed ID: 9166453
    [Abstract] [Full Text] [Related]

  • 10. [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].
    Qiu H, Wang GM.
    Ai Zheng; 2007 Dec 01; 26(12):1392-6. PubMed ID: 18076810
    [Abstract] [Full Text] [Related]

  • 11. [Tolerance dosage of normal tissues by radiotherapy combined with chemotherapy in the group of patients].
    Hishikawa Y.
    Gan No Rinsho; 1990 Oct 01; 36(13):2353-6. PubMed ID: 2250356
    [Abstract] [Full Text] [Related]

  • 12. [Radiotherapy of lung cancer].
    Samija M, Juretić A, Zivković M, Deponte V, Herceg T, Sobat H, Solarić M, Purisić A, Matković I, Tomek R.
    Lijec Vjesn; 1999 Oct 01; 121(11-12):358-66. PubMed ID: 10836086
    [Abstract] [Full Text] [Related]

  • 13. Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): a new concept in radiotherapy and encouraging results in breast cancer.
    Koukourakis MI.
    Semin Oncol; 2002 Dec 01; 29(6 Suppl 19):42-6. PubMed ID: 12577243
    [Abstract] [Full Text] [Related]

  • 14. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
    Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD.
    Clin Cancer Res; 2005 May 01; 11(9):3342-8. PubMed ID: 15867233
    [Abstract] [Full Text] [Related]

  • 15. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Qian H, Wang LJ, Yang HJ, Fu XL, Wu KL, Zang Z, Zhao S.
    Radiother Oncol; 2004 May 01; 71(2):157-62. PubMed ID: 15110448
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment.
    Moeller BJ, Richardson RA, Dewhirst MW.
    Cancer Metastasis Rev; 2007 Jun 01; 26(2):241-8. PubMed ID: 17440683
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of head and neck cancer: radiation therapy].
    Chatani M, Yoshino K.
    Gan To Kagaku Ryoho; 1996 Feb 01; 23(3):271-6. PubMed ID: 8712818
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M, Chapman R, Kim JH.
    Cancer J Sci Am; 1996 Feb 01; 2(6):314-20. PubMed ID: 9166551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.